The latest survey of British Coatings Federation (BCF) members reveals UK coatings manufacturers are increasingly concerned about the effects of the new UK chemical regulations. Almost 80% of respondents believe UK REACH will impact negatively on their businesses, with the fear that there will be a significant reduction in the portfolio of available chemical substances in the UK compared to the EU, and 67% of respondents fear higher costs in the future where suppliers pass on the costs of complying with UK REACH. Worryingly, 19% of respondents are already reporting that EU suppliers no longer want to export to the UK.
The survey also reports challenges for the sector’s UK exporters – 60% fear that having to abide by EU REACH and CLP rules as a ‘third country’ will impact on their business competitiveness, and more than four in ten respondents (43%) reported increased operating costs of more than 5%, with one in ten (9%) citing a figure of more than 10%. These additional cost estimates have increased considerably since the last BCF Brexit Impact Survey at the end of January. On top of these non-tariff costs, the majority of BCF members are still encountering delays to shipping between UK and the EU, and between GB and NI. Overall, after experiencing nearly six months of the new UK-EU trading relationship, half of respondents are still concerned they risk losing EU export customers, and more than a third now worry about their competitiveness compared to EU counterparts as a result of the Trade and Co-operation Agreement (TCA) trading terms. 70% of coatings companies believe their trade with the EU, the sector’s main export market, will reduce, and only 20% see opportunities with the rest of the world from new trade deals.
Tom Bowtell, CEO of the British Coatings Federation, said: “Our latest survey results show that the added complexity of the new UK chemicals regulations is starting to bite. We have consistently called for UK REACH legislation to be amended to avoid the significant additional costs it will bring to business, as well as its potentially devastating impact on raw material availability to our manufacturers in the UK. Failure to amend UK REACH will lead to our coatings members – and other businesses in similar sectors – seeing unsustainable added complexities and extra costs. Exports of chemical-based products from the UK will be severely threatened by UK REACH, as will foreign direct investment into UK factories, as many companies choose to reduce their manufacturing footprint in the UK and relocate to the EU. Overall, the UK will become a less competitive country to do business in.”
“We welcome the fact that Defra has been engaging with industry on the future of UK REACH over the past few months and hope that, even at this late stage, UK REACH can be amended so that it is less damaging to UK businesses.”
In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.
The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.
In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?
High duties on imports from Canada, Mexico and China raise problems for international supply chains.
Advanced Drug Delivery Systems Market, valued at USD 234.84 billion in 2023, is on a trajectory of significant growth, projected to reach USD 352.01 billion by 2032
The U.S. Food and Drug Administration on January 15, 2025, announced its decision to ban Red Dye No. 3 also referred to as Erythrosine.
Targeted drug delivery revolutionises treatment by focusing medications on specific tissues, reducing the impact on healthy cells. Scientists enhance this precision with carriers like microspheres and nanoparticles, controlling release and absorption. Microspheres, made from biodegradable proteins or polymers, sustain drug release, making them ideal for targeted therapies, especially in oncology. Beyond drug delivery, microspheres open new possibilities across industries—from next-gen coatings to thermal insulation. With tailored sizes, shapes, and materials, they drive advancements in pharmaceuticals, advanced materials, and more.
The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos. The FDA noted that this move aims to protect consumers from potential harm posed by asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.
As one of the most significant holidays in China, Chinese New Year (CNY) profoundly impacts global shipping, logistics, and supply chains. Scheduled to begin on January 29, 2025, this festive period lasts up to two weeks, with many factories, ports, and businesses shutting down or operating with limited staff. Understanding the implications of CNY on your supply chain is critical to avoid disruptions and ensure seamless operations.